Hello and Welcome to Patientsville.com, Your Source for all ATROPINE information. We are dedicated to provide You with ATROPINE safety information. Learn about ATROPINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ATROPINE Safety Reports
Total ATROPINE reports: 15.ATROPINE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 8.
Take ATROPINE Side Effects Survey or Share Your ATROPINE Story. Read More Here.
Pharmacist from UNITED STATES reported ATROPINE problem on Mar 07, 2007. Female patient, 48 years of age, was diagnosed with cardiac arrest and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: unevaluable event. ATROPINE dosage: unknown. Patient died on 02/01/2007.
ATROPINE problem was reported by a Pharmacist from UNITED STATES on Mar 07, 2007. Male patient was diagnosed with respiratory arrest and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: unevaluable event. ATROPINE dosage: unknown. Patient died on 02/01/2007.
Consumer or non-health professional from UNITED KINGDOM reported ATROPINE problem on Mar 09, 2007. Male patient, weighting 16.87 lb, was diagnosed with strabismus and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: urinary retention. ATROPINE dosage: unknown. Patient was hospitalized. Patient recovered.
ATROPINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Male patient, 17 years of age, was diagnosed with sedation and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, syncope vasovagal. ATROPINE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ATROPINE problem on June 04, 2007. Male patient, weighting 15.43 lb, was diagnosed with strabismus, keratoconjunctivitis sicca and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: constipation, urinary retention. ATROPINE dosage: unknown. During the same period patient was treated with LACRI. Patient was hospitalized. Patient recovered.
ATROPINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Male patient, 86 years of age, weighting 140.0 lb, was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: bedridden, cardiopulmonary failure, pneumonia. ATROPINE dosage: unknown. Patient was hospitalized. Patient died.
Consumer or non-health professional from FRANCE reported ATROPINE problem on July 06, 2006. Male patient, 41 years of age, was diagnosed with refraction disorder, uveitis and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, headache, loss of employment, mydriasis, photophobia, visual field defect. ATROPINE dosage: unknown. During the same period patient was treated with TOBRAMYCIN, DEXAMETHASONE. Patient recovered.
ATROPINE problem was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 78 years of age, weighting 175.0 lb, was diagnosed with respiratory disorder and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. ATROPINE dosage: unknown. Patient died on 08/03/2006.
Health Professional from FRANCE reported ATROPINE problem on Oct 04, 2006. Male patient, 41 years of age, was diagnosed with diagnostic procedure, uveitis and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, headache, impaired work ability, loss of employment, mydriasis, photophobia, visual field defect. ATROPINE dosage: unknown. During the same period patient was treated with TOBRAMYCIN, DEXAMETHASONE. Patient recovered.
ATROPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 21, 2006. Male patient was diagnosed with gastrointestinal carcinoma, polymyositis and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: muscular weakness, paraparesis. ATROPINE dosage: 0.25 MILLIGRAMS; SUBCUTANEOUS. During the same period patient was treated with PREDNISOLONE PHOSPHATE, IRINOTECAN. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported ATROPINE problem on June 04, 2007. Male patient, weighting 15.43 lb, was diagnosed with strabismus, keratoconjunctivitis sicca and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: constipation, urinary retention. ATROPINE dosage: unknown. During the same period patient was treated with LACRI. Patient was hospitalized. Patient recovered.
ATROPINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Male patient, 62 years of age, was diagnosed with preoperative care and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: fall, hallucination, skin laceration. ATROPINE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ATROPINE problem on July 16, 2007. Male patient, 62 years of age, was diagnosed with preoperative care and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: fall, psychotic disorder, skin laceration. ATROPINE dosage: unknown. Patient was hospitalized. Patient recovered.
ATROPINE problem was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Female patient, 61 years of age, weighting 181.0 lb, was diagnosed with heart rate decreased, percutaneous coronary intervention and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis, cardiac arrest, ventricular fibrillation, vomiting. ATROPINE dosage: 1 MG, ONCE, INTRAVENOUS. During the same period patient was treated with EPINEPHRINE, HEPARIN I, ANGIOMAX, INTEGRILIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ATROPINE problem on Aug 27, 2007. Male patient, 62 years of age, was diagnosed with preoperative care and was treated with ATROPINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, cerebellar atrophy, cerebral atrophy, contusion, convulsion, encephalitis toxic, fall, psychotic disorder, sensory disturbance. ATROPINE dosage: unknown. During the same period patient was treated with BETA BLOCKING AGENTS, OXYCONTIN, ACYCLOVIR, ERGOCALCIFEROL, ESOMEPRAZOLE MAGNESIUM, FLUCONAZOLE, HYDROCORTISONE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.